Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health
National Heart, Lung, and Blood Institute
Robert J. Lederman, MD, is a senior investigator at the NHLBI, where he leads a program to develop new non-surgical catheter treatments for cardiovascular disease, and that develops and refines radiation-free catheterization using MRI in patients.
He and his team have invented a range of interventional procedures including mitral cerclage annuloplasty for mitral regurgitation, transatrial intrapericardial tricuspid annuloplasty for tricuspid regurgitation, transcaval aortic access, and intentional laceration of the mitral valve to prevent LVOT obstruction after transcatheter mitral valve replacement. His laboratory collaborates with Henry Ford Hospital in Detroit MI and Emory University in Atlanta GA to develop and test new structural heart procedures, and Childrens National Medical Center in Washington DC to introduce MRI catheterization into clinical practice.
Director, Center for Interventional Vascular Therapy
Columbia University Medical Center
Cardiovascular Research Foundation
Martin B. Leon, MD, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the NewYork-Presbyterian/Columbia Heart Valve Center. Dr. Leon was the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. CRF is the largest independent not-for-profit cardiovascular research center in the United States.
A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis.
Professor and Chairman
Department of Cardiology, Bern University Hospital
Since 2015, Prof. Windecker has been the Chairman and Director of the Department of Cardiology at the Swiss Cardiovascular Center Bern, Switzerland. He is an interventional cardiologist by training and has previously served as Director of Invasive Cardiology at Bern University Hospital from 2002 to 2015. He is full Professor of Cardiology at the University of Bern, Switzerland and executive board member of the Clinical Trials Unit at Bern University Hospital. Prof. Windecker is currently Chairman of the Clinical Practice Guidelines Committee of the European Society of Cardiology . He is also one of the course directors of EuroPCR and PCR London Valves. Prof. Windecker has been a Fulbright scholar and received the I2-summit Innovator 2005 Award of the American College of Cardiology.
Prof. Windecker’s main research interests focus on the evaluation of intracoronary devices for the treatment of coronary artery disease, research related to structural heart disease including transcatheter aortic, mitral, and tricuspid valve interventions, patent foramen ovale (PFO), left atrial appendage occlusion as well as percutaneous left ventricular assist devices.
University of Michigan Health Systems
University of Michigan Frankel Cardiovascular Center
Dr. Steven F. Bolling is a Professor of Surgery in the Department of Cardiac Surgery at the University of Michigan. Both his undergraduate and medical school education were at the University of Michigan. Following this, he trained in general and thoracic surgery at Johns Hopkins.
He joined the Cardiac Surgery faculty at the University of Michigan in the mid-1980s and helped create and direct the multi-disciplinary mitral valve clinic. He is an active participant in all the major cardiac surgical societies and a recognized expert in mitral valve surgery. He is the author of over 350 peer-reviewed publications and holds numerous grants, including NIH, AHA, and industry grants.
He is the Director of the Myocellular Biology Laboratory. His research is in the molecular biology of heart failure, with a special interest in myocyte signal transduction. He is also the Director of the Multidisciplinary Mitral Valve Clinic.
Dr. Liberman is Professor of Medicine (Cardiology) at Emory University School of Medicine and Director of the Cardiac Cath Lab and Interventional cardiology at Emory University Midtown. His main research interest are Acute Myocardial Infarction and Complex Coronary Intervention.
Clinical Associate Professor
Dr. Saw is an Interventional Cardiologist at VGH, with joint appointment at St Paul’s Hospital. She is a Clinical Associate Professor of Medicine at UBC, and Program Director of the Interventional Cardiology Fellowship Program at VGH.
Dr. Saw’s research interests include spontaneous coronary artery dissection, antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral intervention, LAA closure, and non-atherosclerotic coronary artery disease including SCAD and coronary fibromuscular dysplasia. She is the principal investigator of the Canadian SCAD Study, PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG and ELAPSE studies.
Professor of Medicine
University of North Carolina
University of North Carolina School of Medicine
George 'Rick' Stouffer, MD is the Henry A. Foscue Distinguished Professor of Medicine and Chief of Cardiology at the University of North Carolina. He received degrees in Mechanical Engineering and Mathematics from Bucknell University and an MD degree from the University of Maryland School of Medicine. He completed internal medicine residency, cardiology fellowship, and interventional cardiology fellowship at the University of Virginia and was on the faculty at the University of Texas Medical Branch prior to going to UNC. Dr. Stouffer's research is in smooth muscle cell growth regulation, the role of the cytoskeleton in regulating signaling pathways, thrombin generation, and renal artery stenosis.
Co-director, Center for Structural Heart Disease
Henry Ford Hospital
Wayne State University
Wellspan Health York Hospital / Emory University
Dr. William Nicholson is an interventional cardiologist practicing in York, Pennsylvania. He is the Director of Invasive Cardiology, Complex PCI/CTO and Structural Heart Disease at York Hospital. Dr. Nicholson also serves as an adjunct Assistant Professor at Emory University.